Comparison of the effects of novel antimuscarinic drugs on human detrusor smooth muscle

BJU International

Volumn 86, Issue 6, 2000, Pages 719-725

  Yono, M ^a   Yoshida, M ^a   Takahashi, W ^a   Inadome, A ^a   Ueda, S ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Human urinary bladder; Temiverine; Tolterodine; Vamicamide

Indexed keywords

ATROPINE; CALCIUM CHLORIDE; CARBACHOL; MUSCARINIC RECEPTOR BLOCKING AGENT; POTASSIUM CHLORIDE; TEMIVERINE; TOLTERODINE; UNCLASSIFIED DRUG; VAMICAMIDE;

ADULT; AGED; ARTICLE; BLADDER CONTRACTION; CONCENTRATION RESPONSE; DETRUSOR MUSCLE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; ELECTROSTIMULATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; URINE INCONTINENCE;

AGED; BENZHYDRYL COMPOUNDS; BLADDER; BLADDER NEOPLASMS; CARBACHOL; CHOLINERGIC ANTAGONISTS; CRESOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMAN; MALE; MUSCARINIC ANTAGONISTS; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PHENYLACETATES; PYRIDINES;

EID: 0033775959     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2000.00892.x     Document Type: Article

References (30)

1. Steers WD. Physiology and pharmacology of the bladder and urethra. In Walsh PC, Retik AB, Vaughan ED Jr, Wein AJ eds, Campbell's Urology, 7th edn, Vol. I, Chapt. 26 Philadelphia: WB Saunders, 1997: 870-915
2. Andersson K-E, Fovaeus M, Hedlund H, Urogenital muscarinic receptors and drug effects. Ann Clin Res 1988; 20: 356-66
3. Naerger H, Fry CH, Nilvebrant L. Effect of tolterodine on electrically induced contractions of isolated human detrusor muscle from stable and unstable bladders. Neurourol Urodyn 1995; 14: 524-6
4. Nilvebrant L, Stahl M, Andersson K-E. Interaction of tolterodine with cholinergic muscarinic receptors in human detrusor. Neurourol Urodyn 1995; 14: 523-4
5. Yamamoto T, Koibuchi Y, Miura S et al. Effects of vamicamide on urinary bladder functions in conscious dog and rat models of urinary frequency. J Urol 1995; 154: 2174-8
6. Yamamoto T, Matsuo M, Yamazaki S et al. Antimuscarinic properties of vamicamide, a novel compound for the treatment of pollakiuria. Drug Dev Res 1995; 34: 9-18
7. Hamada K, Sasaki Y, Taniguchi N et al. Anticholinergic and calcium antagonistic activities of NS-21 contribute to the inhibition of rat urinary bladder contractions. Gen Pharmacol 1997; 29: 771-8
8. Kikukawa H, Yoshida M, Wada Y, Nishi K, Ueda S. Pharmacologic actions of temiverine (p-INN) and its active metabolite, RCC-36, on isolated human urinary bladder muscle. Int J Urol 1998; 5: 268-75
9. Nilvebrant L, Glas G, Jönsson A, Sparf B. The in vitro pharmacological profile of tolterodine - a new agent for the treatment of urinary urge incontinence. Neurourol Urodyn 1994; 13: 433-5
10. Nilvebrant L, Andersson K-E, Gillberg P-G, Stahl M, Sparf B. Tolterodine - a new bladder-selective antimuscarinic agent. Eur J Pharmacol 1997; 327: 195-207
11. Nilvebrant L, Hallén B, Larsson G. Tolterodine - a new bladder selective muscarinic receptor antagonist: preclinical pharmacological and clinical data. Life Sci 1997; 60: 1129-36
12. Oyasu H, Yamamoto T, Sato N et al. Urinary bladder-selective action of the new antimuscarinic compound vamicamide. Arzneim-Forsch/Drug Res 1994; 44: 1242-9
13. Yamamoto T, Honbo T, Tokoro K et al. General pharmacology of the new antimuscarinic compound vamicamide. Arzneim-Forsch/Drug Res 1995; 45: 1274-84
14. Wada Y, Yoshida M, Kitani K et al. Comparison of the effects of various anticholinergic drugs on human isolated urinary bladder. Arch M Pharmacodyn 1995; 330: 76-89
15. Arunlakshana O, Schild HO. Some quantitative uses of drug antagonists. Br J Pharmacol 1959; 14: 48-58
16. Caulfield MP, Birdsall NJM. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 1998; 50: 279-90
17. Wang P, Luthin GR, Ruggieri MR. Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins. J Pharmacol Exp Ther 1995; 273: 959-66
18. Gillberg P-G, Sundquist S, Nilvebrant L. Comparison of the in vitro and in vivo profiles of tolterodine with those of subtype-selective muscarinic receptor antagonists. Eur J Pharmacol 1998; 349: 285-92
19. Nilvebrant L, Gillberg P-G, Sparf B. Antimuscarinic potency and bladder selectivity of PNU-200577. a major metabolite of tolterodine. Pharmacol Toxicol 1997; 81: 169-72
20. 1 muscarinic receptor-mediated facilitation of acetylcholine release in the rat urinary bladder. J Physiol 1994; 480: 81-9
21. 3H]acetylcholine in the rabbit urinary bladder. Eur J Pharmacol 1995; 281: 1-8
22. Eglen RM, Reddy H, Watson N, Challiss RAJ. Muscarinic acetylcholine receptor subtypes in smooth muscle. Trends Pharmacol Sci 1994; 15: 114-9
23. Aida Y, Kaneko Y, Kasama T. Effect of oxybutynin hydrochloride on isolated smooth muscles (ileum, urinary bladder and urethra). Folia Pharmacol Jpn 1986; 87: 629-39
24. Haruno A, Yamasaki Y, Miyoshi K et al. Effects of propiverine hydrochloride and its metabolites on isolated guinea pig urinary bladder. Folia Pharmacol Jpn 1989; 94: 145-50
25. Luheshi G, Zar A. Purinoceptor desensitization impairs but does not abolish the non-cholinergic motor transmission in rat isolated urinary bladder. Eur J Pharmacol 1990; 185: 203-8
26. Zar MA, Iravani MM, Luheshi GN. Effect of nifedipine on the contractile responses of the isolated rat bladder. J Urol 1990; 143: 835-9
27. Sjögren C, Andersson K-E, Husted S, Mattiasson A, Moller-Madsen B. Atropine resistance of transmurally stimulated isolated human bladder muscle. J Urol 1982: 128: 1368-71
28. Palea S, Artibani W, Ostardo E, Trist DG, Pietra C. Evidence for purinergic neurotransmission in human urinary bladder affected by interstitial cystitis. J Urol 1993; 150: 2007-12
29. Saito M, Kondo A, Kato T, Levin RM. Response of isolated human neurogenic detrusor smooth muscle to intramural nerve stimulation. Br J Urol 1993; 72: 723-7
30. Yokota T, Yamaguchi O. Changes in cholinergic and purinergic neurotransmission in pathologic bladder of chronic spinal rabbit. J Urol 1996; 156: 1862-6